Streetbeat News

Regulatory

MIST

Milestone Pharmaceuticals announced the publication of results from its Phase 3 RAPID clinical trial of Etripamil nasal spray in patients with PSVT in The Lancet. The trial demonstrated the efficacy and safety of the drug.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:18 am

DGICA

NVCT

ODC

Insiders have recently made notable purchases in Donegal Group Inc. (DGICA), Nuvectis Pharma, Inc. (NVCT), and Oil-Dri Corporation of America (ODC). Donegal posted downbeat quarterly earnings, Nuvectis Pharma announced FDA clearance of NXP900 IND, and Oil-Dri Corp of America reported an increase in third-quarter sales.

Portfolio Pulse from Lisa Levin

June 20, 2023 | 11:01 am

BR

Broadridge Financial Solutions (BR) has been granted a patent for its machine learning technology designed to enhance securities-based lending. The technology aims to improve risk management and streamline the lending process.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 11:01 am

BABA

FDX

LZB

QQQ

SPY

US stock futures pull back as traders focus on Fed speeches and Powell's testimony. China's central bank cuts key lending rates, while the US market experienced solid gains last week. Analyst Adam Turnquist says evidence of a regime shift from high to low implied volatility is building, which bodes well for the market.

Portfolio Pulse from Shanthi Rexaline

June 20, 2023 | 10:47 am

NVDA

Despite US sanctions, Nvidia's high-end AI chips are being sold in China's underground market at double the usual price. The US export restrictions have created a de facto underground market, with vendors keen to avoid scrutiny from both US and Chinese authorities.

Portfolio Pulse from Benzinga Newsbot

June 20, 2023 | 10:38 am

ABT

SRDX

Surmodics has received FDA approval for its SurVeil Drug-Coated Balloon (DCB). Abbott holds exclusive worldwide commercialization rights for the product, and Surmodics will manufacture and supply it. Surmodics will receive a $27 million milestone payment from Abbott and expects to recognize $24.0 to $24.5 million of revenue in Q3 of fiscal year 2023.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 10:34 am

AGR

PNM

PNM Resources and Avangrid have agreed to extend their merger agreement through December 31, 2023. The extension allows both companies more time to complete the necessary regulatory approvals.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 10:31 am

ATXG

Addentax Group (ATXG) received a notice from Nasdaq on June 15 stating that the company did not meet the minimum bid price requirement.

Portfolio Pulse from Charles Gross

June 20, 2023 | 10:08 am

TSLA

Tesla has been granted two U.S. patents: one for a computational array microprocessor system using non-consecutive data formatting, and another for methods and apparatuses for energy storage device electrode fabrication.

Portfolio Pulse from Charles Gross

June 20, 2023 | 9:20 am

ADBE

VGK

Adobe's acquisition of Figma is under threat from EU regulators, potentially impacting the deal's completion.

Portfolio Pulse from Charles Gross

June 20, 2023 | 9:04 am